Shares of Australia-based Bionomics (ASX:BNOX), listed in the U.S., nearly tripled to $2.87 in pre-market trading.

The company announced that their experimental drug for post-traumatic stress disorder (PTSD) demonstrated a reduction in severity of symptoms during a mid-stage study.

The experimental drug candidate, BNC210, also exhibited an improvement in depressive symptoms and sleep quality according to Bionomics (ASX:BNOX).

The company stated that BNC210 was safe and well-tolerated during the study and plans to advance the treatment for PTSD into further registrational studies.

Up to the last closing, Bionomics (ASX:BNOX) U.S.-listed shares were down approximately 79% for the year to date.

Bionomics (ASX:BNOX) is an Australia-based biopharmaceutical company that develops and discovers innovative therapeutics for cancer and diseases of the central nervous system.

U.S.-listed shares of Australia-based Bionomics rise by 26.9% to $1.23 in premarket trading.

The company has reported that its experimental drug to treat post-traumatic stress disorder (PTSD) demonstrated a reduction in the severity of symptoms during a mid-stage study.

The drug candidate, referred to as BNC210, also showed improvements in depressive symptoms and better sleep.

The company confirmed that BNC210 was found to be safe and was well-tolerated within their study.

Bionomics plans to advance their drug candidate, BNC210, into registrational studies as a treatment for PTSD.

Up to the last close, Bionomics' U.S.-listed shares have been down approximately 79% year-to-date.

Bionomics is an Australian company that develops drugs to treat serious neurological conditions.

Lee Huey Chyuan has been promoted to the role of CFO at ST Group Food Industries Holdings (ASX:STGR).

The announcement came as a confirmation of his elevation in the company’s financial department.

ST Group Food Industries Holdings is a company involved in the food manufacturing industry.

Southern Palladium (ASX:SPD) revealed a headline loss per share of A$0.08 for the fiscal year in a financial report.

The disclosure follows the end of the financial year on 30 June 2023.

Southern Palladium (ASX:SPD) is a mining company that deals with the extraction and processing of palladium.

For the recently concluded fiscal year, Otto Energy (ASX:OEL) posted a net loss after tax of $7.0 million.

The loss reflects a significant shift from the previous fiscal year’s profit of $15.5 million.

The oil and gas company also reported that its net operating revenue stood at $33.4 million, a decrease from the previous year’s figure of $40.6 million.

Otto Energy is an oil and gas production and exploration company.

Lightning Minerals (ASX:L1M) has made significant changes to its executive board.

Peter McNeil, the company’s non-executive chairman, has resigned from his directorial position.

A new Chief Executive Officer, Alex Biggs, has been appointed.

Until a new permanent chairman is selected, non-executive director Craig Sharpe will fill in as the interim Chairman of the Board.

Furthermore, Alex Biggs will also take on the role of Managing Director.

Lightning Minerals is a mineral exploration company.

Ora Banda Mining (ASX:OBM) has reported a full year total comprehensive loss of A$44.2 million, compared with a loss of A$88 million from the previous year.

The company also posted a decrease in revenue, with a reported figure of A$135.9 million, down from A$154.3 million.

Ora Banda Mining is a gold exploration and mining company with key operations in the Eastern Goldfields district of Western Australia.

Shares of the Sydney-based toll road company, Atlas Arteria (ASX:ALX), fell dramatically by up to 5.4% to A$5.430, a record low since May 2021.

The significant drop could result in the company’s worst day since September 2022, given the losses sustain.

Atlas Arteria’s French highway might be subjected to a new annual tax, following the release of France’s 2024 budget plan.

The proposed bill includes a new tax to be effective from 2024, specifically targeting companies that handle long-haul transport infrastructure.

Atlas Arteria, owning approximately a 31% stake in France’s 2,318-km Autoroutes Paris-Rhin-Rhone (APRR) tollway, is expected to feel the impact.

As of the last close, the company’s shares were down by 13.2% Year To Date.

Atlas Arteria is a company headquartered in Australia, specializing in developing toll road infrastructure.

Shares of Metal Hawk saw an increase of as much as 15% to A$0.115, marking the largest intraday percentage jump since September 8.

The mineral exploration company confirmed the completion of an electro-magnetic survey at the Yarmany tenement area, a part of their Yarmany project in Western Australia.

Metal Hawk (ASX:MHK) reported the discovery of strong bedrock conductors in the area, considered to be high priority targets for drilling.

Furthermore, rockchip samples from the Reptile Dam prospect within the project have exhibited extraordinarily anomalous results for both nickel and copper.

Despite these recent gains, the company’s shares are down 39.4% year-to-date from the last recorded close.

Metal Hawk (ASX:MHK) is a mineral exploration company known for its efforts in developing projects in Western Australia.

Shares in Australian software provider, Identitii (ASX:ID8) rose by 8.3% to A$0.013, recording their largest intraday percentage gain since September 12.

The company announced A$1.0 million in annualised cost savings, which will further extend its financial runway.

Identitii (ASX:ID8) anticipates that this cost-saving measure will result in decreased cash outflows in the upcoming financial quarters.

The savings were realized in areas such as cloud infrastructure, legal expenses, operational costs, and reduced employee count, according to Identitii.

They achieved these savings without affecting their growth objectives.

Despite the day’s gains, the company’s stock is down by 52% this year.

Identitii is an Australian software company that specializes in data management solutions.